BRENTWOOD, Tenn., Feb. 28, 2017 -- Delek Logistics Partners, LP (NYSE:DKL) today announced that Uzi Yemin, Chairman and CEO, Mark Smith, EVP and other members of Delek Logistics’ General Partner’s management will participate in the Barclays MLP Corporate Access Day in New York, New York on Wednesday, March 1, 2017.
A copy of Delek Logistics’ latest investor presentation will be provided at the conference. An electronic copy of this presentation is currently available in the “Investors” section of the Delek Logistics website at www.deleklogistics.com.
About Delek Logistics Partners, LP
Delek Logistics Partners, LP, headquartered in Brentwood, Tennessee, was formed by Delek US Holdings, Inc. (NYSE:DK) to own, operate, acquire and construct crude oil and refined products logistics and marketing assets.
U.S. Investor / Media Relations Contact: Keith Johnson Vice President of Investor Relations Delek Logistics Partners, LP 615-435-1366


L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 



